Immunosuppressive Therapy for Diabetics after Renal Transplantation

  • Daniel M. Canafax
  • David E. R. Sutherland
  • John S. Najarian
Part of the Topics in Renal Medicine book series (TIRM, volume 6)

Abstract

Uremia is the major cause of death in patients who live more than 20 years after the onset of insulin-dependent diabetes mellitus. Until recently, most uremic diabetics were not treated with dialysis and transplantation.

Keywords

Renal Allograft Nondiabetic Patient Graft Survival Rate Immunosuppressive Protocol Trans Plant 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Sutherland DER, Strand MH, Canafax DM, et al.: Results of the Minnesota randomized prospective trial of cyclosporine versus azathioprine—antilymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kidney Dis 5: 318–327, 1985.PubMedGoogle Scholar
  2. 2.
    Simmons RL, Canafax DM, Fryd DS, et al.: New immunosuppressive drug combinations for mismatched related and cadaveric renal transplantation. Transplant Proc [Suppl 11: 18: 76–81, 1986.Google Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1988

Authors and Affiliations

  • Daniel M. Canafax
  • David E. R. Sutherland
  • John S. Najarian

There are no affiliations available

Personalised recommendations